| Disease associated variation - GWASdb |
| Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
|---|
| 3 | 32880078 | rs12629685 | G | A | rs12629685 | 0.0001982 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
| 3 | 32880078 | rs12629685 | G | A | rs12629685 | 1.98E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
| 3 | 32882007 | rs13075951 | G | A | rs13075951 | 0.0001987 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
| 3 | 32882007 | rs13075951 | G | A | rs13075951 | 1.99E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
| 3 | 32880078 | rs12629685 | G | A | rs12629685 | 0.0001982 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
| 3 | 32880078 | rs12629685 | G | A | rs12629685 | 1.98E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
| 3 | 32882007 | rs13075951 | G | A | rs13075951 | 0.0001987 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
| 3 | 32882007 | rs13075951 | G | A | rs13075951 | 1.99E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
| 3 | 32883189 | rs7610310 | G | A | rs7610310 | 2.52E-06 | | | Schizophrenia | HPOID:0100753 | DOID:5419 | A | intron | GWASdb_trait |
| 3 | 32883581 | rs997520 | G | A | rs997520 | 2.74E-06 | | | Schizophrenia | HPOID:0100753 | DOID:5419 | A | intron | GWASdb_trait |
| 3 | 32929115 | rs9310995 | T | C | rs9310995 | 4.00E-06 | | | Pulmonary function | HPOID:0002795 | DOID:2841|DOID:3083 | C | intron | GWASdb_trait |